Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study
Identifieur interne : 002272 ( PascalFrancis/Checkpoint ); précédent : 002271; suivant : 002273Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study
Auteurs : H. G. Mar Fan [Canada, Australie] ; N. Houede-Tchen [Canada, France] ; I. Chemerynsky [Canada] ; Q.-L. Yi [Canada] ; W. Xu [Canada] ; B. Harvey [Canada] ; I. F. Tannock [Canada]Source :
- Annals of oncology [ 0923-7534 ] ; 2010.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme, Adulte, Femme, Prospective.
English descriptors
- KwdEn :
Abstract
Background: Women with breast cancer frequently undergo menopause following adjuvant chemotherapy. Here, we investigated whether they have more severe symptoms than women undergoing natural menopause. Patients and methods: Forty-one women who had undergone menopause as a result of chemotherapy and 57 healthy women who had undergone recent natural menopause were evaluated on two occasions 1 year apart. The primary end point was the summed score of the self-report Functional Assessment of Cancer Therapy, endocrine symptoms (FACT-ES) scale. Quality of life was evaluated by the FACT-G questionnaire and fatigue by the FACT-F subscale. Results: There was a strong trend for patients to report worse FACT-ES scores than controls at the first (P = 0.05) and second (P = 0.04) time points. More patients had moderate/severe hot flashes than controls undergoing natural menopause (51 % versus 19%, P = 0.003). Patients reported worse fatigue than controls at the first assessment (P = 0.04), with no difference at the second. Menopausal symptoms were associated with fatigue for both groups. There was no difference between patients and controls in the quality-of-life scale, although assessment of patients is likely subject to adaptation and response-shift bias. Conclusions: Women undergoing chemotherapy-induced menopause may experience worse symptoms than women undergoing natural menopause.
Affiliations:
- Australie, Canada, France
- Aquitaine, Nouvelle-Aquitaine, Ontario
- Bordeaux, Toronto
- Université de Toronto
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:10-0265852Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study</title><author><name sortKey="Mar Fan, H G" sort="Mar Fan, H G" uniqKey="Mar Fan H" first="H. G." last="Mar Fan">H. G. Mar Fan</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medical Oncology, Princess Alexandra Hospital</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane, Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Houede Tchen, N" sort="Houede Tchen, N" uniqKey="Houede Tchen N" first="N." last="Houede-Tchen">N. Houede-Tchen</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Medical Oncology, Institut Bergonié</s1><s2>Bordeaux</s2><s3>FRA</s3><sZ>2 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Chemerynsky, I" sort="Chemerynsky, I" uniqKey="Chemerynsky I" first="I." last="Chemerynsky">I. Chemerynsky</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Yi, Q L" sort="Yi, Q L" uniqKey="Yi Q" first="Q.-L." last="Yi">Q.-L. Yi</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Biostatistics, Canadian Blood Services</s1><s2>Ottawa, Ontario</s2><s3>CAN</s3><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Ottawa, Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Xu, W" sort="Xu, W" uniqKey="Xu W" first="W." last="Xu">W. Xu</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Harvey, B" sort="Harvey, B" uniqKey="Harvey B" first="B." last="Harvey">B. Harvey</name><affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Department of Family and Community Medicine, University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>6 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Tannock, I F" sort="Tannock, I F" uniqKey="Tannock I" first="I. F." last="Tannock">I. F. Tannock</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">10-0265852</idno><date when="2010">2010</date><idno type="stanalyst">PASCAL 10-0265852 INIST</idno><idno type="RBID">Pascal:10-0265852</idno><idno type="wicri:Area/PascalFrancis/Corpus">002649</idno><idno type="wicri:Area/PascalFrancis/Curation">003937</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002272</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">002272</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study</title><author><name sortKey="Mar Fan, H G" sort="Mar Fan, H G" uniqKey="Mar Fan H" first="H. G." last="Mar Fan">H. G. Mar Fan</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Medical Oncology, Princess Alexandra Hospital</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Brisbane, Queensland</wicri:noRegion></affiliation></author><author><name sortKey="Houede Tchen, N" sort="Houede Tchen, N" uniqKey="Houede Tchen N" first="N." last="Houede-Tchen">N. Houede-Tchen</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Department of Medical Oncology, Institut Bergonié</s1><s2>Bordeaux</s2><s3>FRA</s3><sZ>2 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Nouvelle-Aquitaine</region><region type="old region">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Chemerynsky, I" sort="Chemerynsky, I" uniqKey="Chemerynsky I" first="I." last="Chemerynsky">I. Chemerynsky</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Yi, Q L" sort="Yi, Q L" uniqKey="Yi Q" first="Q.-L." last="Yi">Q.-L. Yi</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Biostatistics, Canadian Blood Services</s1><s2>Ottawa, Ontario</s2><s3>CAN</s3><sZ>4 aut.</sZ></inist:fA14><country>Canada</country><wicri:noRegion>Ottawa, Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Xu, W" sort="Xu, W" uniqKey="Xu W" first="W." last="Xu">W. Xu</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Harvey, B" sort="Harvey, B" uniqKey="Harvey B" first="B." last="Harvey">B. Harvey</name><affiliation wicri:level="4"><inist:fA14 i1="05"><s1>Department of Family and Community Medicine, University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>6 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Tannock, I F" sort="Tannock, I F" uniqKey="Tannock I" first="I. F." last="Tannock">I. F. Tannock</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author></analytic><series><title level="j" type="main">Annals of oncology</title><title level="j" type="abbreviated">Ann. oncol.</title><idno type="ISSN">0923-7534</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Annals of oncology</title><title level="j" type="abbreviated">Ann. oncol.</title><idno type="ISSN">0923-7534</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Breast cancer</term><term>Chemotherapy</term><term>Fatigue</term><term>Female</term><term>Human</term><term>Menopause</term><term>Prospective</term><term>Quality of life</term><term>Symptomatology</term><term>Woman</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Ménopause</term><term>Symptomatologie</term><term>Homme</term><term>Femelle</term><term>Adulte</term><term>Femme</term><term>Chimiothérapie</term><term>Prospective</term><term>Cancer du sein</term><term>Fatigue</term><term>Qualité de vie</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term><term>Adulte</term><term>Femme</term><term>Prospective</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: Women with breast cancer frequently undergo menopause following adjuvant chemotherapy. Here, we investigated whether they have more severe symptoms than women undergoing natural menopause. Patients and methods: Forty-one women who had undergone menopause as a result of chemotherapy and 57 healthy women who had undergone recent natural menopause were evaluated on two occasions 1 year apart. The primary end point was the summed score of the self-report Functional Assessment of Cancer Therapy, endocrine symptoms (FACT-ES) scale. Quality of life was evaluated by the FACT-G questionnaire and fatigue by the FACT-F subscale. Results: There was a strong trend for patients to report worse FACT-ES scores than controls at the first (P = 0.05) and second (P = 0.04) time points. More patients had moderate/severe hot flashes than controls undergoing natural menopause (51 % versus 19%, P = 0.003). Patients reported worse fatigue than controls at the first assessment (P = 0.04), with no difference at the second. Menopausal symptoms were associated with fatigue for both groups. There was no difference between patients and controls in the quality-of-life scale, although assessment of patients is likely subject to adaptation and response-shift bias. Conclusions: Women undergoing chemotherapy-induced menopause may experience worse symptoms than women undergoing natural menopause.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0923-7534</s0></fA01><fA03 i2="1"><s0>Ann. oncol.</s0></fA03><fA05><s2>21</s2></fA05><fA06><s2>5</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study</s1></fA08><fA11 i1="01" i2="1"><s1>MAR FAN (H. G.)</s1></fA11><fA11 i1="02" i2="1"><s1>HOUEDE-TCHEN (N.)</s1></fA11><fA11 i1="03" i2="1"><s1>CHEMERYNSKY (I.)</s1></fA11><fA11 i1="04" i2="1"><s1>YI (Q.-L.)</s1></fA11><fA11 i1="05" i2="1"><s1>XU (W.)</s1></fA11><fA11 i1="06" i2="1"><s1>HARVEY (B.)</s1></fA11><fA11 i1="07" i2="1"><s1>TANNOCK (I. F.)</s1></fA11><fA14 i1="01"><s1>Division of Medical Oncology and Hematology, Princess Margaret Hospital and University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>7 aut.</sZ></fA14><fA14 i1="02"><s1>Department of Medical Oncology, Princess Alexandra Hospital</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ></fA14><fA14 i1="03"><s1>Department of Medical Oncology, Institut Bergonié</s1><s2>Bordeaux</s2><s3>FRA</s3><sZ>2 aut.</sZ></fA14><fA14 i1="04"><s1>Department of Biostatistics, Canadian Blood Services</s1><s2>Ottawa, Ontario</s2><s3>CAN</s3><sZ>4 aut.</sZ></fA14><fA14 i1="05"><s1>Department of Family and Community Medicine, University of Toronto</s1><s2>Toronto, Ontario</s2><s3>CAN</s3><sZ>6 aut.</sZ></fA14><fA20><s1>983-987</s1></fA20><fA21><s1>2010</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>22429</s2><s5>354000181132910130</s5></fA43><fA44><s0>0000</s0><s1>© 2010 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>18 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>10-0265852</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Annals of oncology</s0></fA64><fA66 i1="01"><s0>GBR</s0></fA66><fC01 i1="01" l="ENG"><s0>Background: Women with breast cancer frequently undergo menopause following adjuvant chemotherapy. Here, we investigated whether they have more severe symptoms than women undergoing natural menopause. Patients and methods: Forty-one women who had undergone menopause as a result of chemotherapy and 57 healthy women who had undergone recent natural menopause were evaluated on two occasions 1 year apart. The primary end point was the summed score of the self-report Functional Assessment of Cancer Therapy, endocrine symptoms (FACT-ES) scale. Quality of life was evaluated by the FACT-G questionnaire and fatigue by the FACT-F subscale. Results: There was a strong trend for patients to report worse FACT-ES scores than controls at the first (P = 0.05) and second (P = 0.04) time points. More patients had moderate/severe hot flashes than controls undergoing natural menopause (51 % versus 19%, P = 0.003). Patients reported worse fatigue than controls at the first assessment (P = 0.04), with no difference at the second. Menopausal symptoms were associated with fatigue for both groups. There was no difference between patients and controls in the quality-of-life scale, although assessment of patients is likely subject to adaptation and response-shift bias. Conclusions: Women undergoing chemotherapy-induced menopause may experience worse symptoms than women undergoing natural menopause.</s0></fC01><fC02 i1="01" i2="X"><s0>002B02R</s0></fC02><fC02 i1="02" i2="X"><s0>002B20E02</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Ménopause</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Menopause</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Menopausia</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Symptomatologie</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Symptomatology</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Sintomatología</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Homme</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Human</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Hombre</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Femelle</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Female</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Hembra</s0><s5>04</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Adulte</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Adult</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Adulto</s0><s5>05</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Femme</s0><s5>06</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Woman</s0><s5>06</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Mujer</s0><s5>06</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Chimiothérapie</s0><s5>07</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Chemotherapy</s0><s5>07</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Quimioterapia</s0><s5>07</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Prospective</s0><s5>09</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Prospective</s0><s5>09</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Prospectiva</s0><s5>09</s5></fC03><fC03 i1="09" i2="X" l="FRE"><s0>Cancer du sein</s0><s2>NM</s2><s5>10</s5></fC03><fC03 i1="09" i2="X" l="ENG"><s0>Breast cancer</s0><s2>NM</s2><s5>10</s5></fC03><fC03 i1="09" i2="X" l="SPA"><s0>Cáncer del pecho</s0><s2>NM</s2><s5>10</s5></fC03><fC03 i1="10" i2="X" l="FRE"><s0>Fatigue</s0><s5>11</s5></fC03><fC03 i1="10" i2="X" l="ENG"><s0>Fatigue</s0><s5>11</s5></fC03><fC03 i1="10" i2="X" l="SPA"><s0>Fatiga</s0><s5>11</s5></fC03><fC03 i1="11" i2="X" l="FRE"><s0>Qualité de vie</s0><s5>12</s5></fC03><fC03 i1="11" i2="X" l="ENG"><s0>Quality of life</s0><s5>12</s5></fC03><fC03 i1="11" i2="X" l="SPA"><s0>Calidad vida</s0><s5>12</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Traitement</s0></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Treatment</s0></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Tratamiento</s0></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Tumeur maligne</s0><s2>NM</s2><s5>37</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Malignant tumor</s0><s2>NM</s2><s5>37</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Tumor maligno</s0><s2>NM</s2><s5>37</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Cancer</s0><s2>NM</s2></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Cancer</s0><s2>NM</s2></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Cáncer</s0><s2>NM</s2></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Pathologie de la glande mammaire</s0><s2>NM</s2><s5>38</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Mammary gland diseases</s0><s2>NM</s2><s5>38</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Glándula mamaria patología</s0><s2>NM</s2><s5>38</s5></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Pathologie du sein</s0><s2>NM</s2><s5>39</s5></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Breast disease</s0><s2>NM</s2><s5>39</s5></fC07><fC07 i1="05" i2="X" l="SPA"><s0>Seno patología</s0><s2>NM</s2><s5>39</s5></fC07><fN21><s1>172</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>Australie</li><li>Canada</li><li>France</li></country><region><li>Aquitaine</li><li>Nouvelle-Aquitaine</li><li>Ontario</li></region><settlement><li>Bordeaux</li><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><country name="Canada"><region name="Ontario"><name sortKey="Mar Fan, H G" sort="Mar Fan, H G" uniqKey="Mar Fan H" first="H. G." last="Mar Fan">H. G. Mar Fan</name></region><name sortKey="Chemerynsky, I" sort="Chemerynsky, I" uniqKey="Chemerynsky I" first="I." last="Chemerynsky">I. Chemerynsky</name><name sortKey="Harvey, B" sort="Harvey, B" uniqKey="Harvey B" first="B." last="Harvey">B. Harvey</name><name sortKey="Houede Tchen, N" sort="Houede Tchen, N" uniqKey="Houede Tchen N" first="N." last="Houede-Tchen">N. Houede-Tchen</name><name sortKey="Tannock, I F" sort="Tannock, I F" uniqKey="Tannock I" first="I. F." last="Tannock">I. F. Tannock</name><name sortKey="Xu, W" sort="Xu, W" uniqKey="Xu W" first="W." last="Xu">W. Xu</name><name sortKey="Yi, Q L" sort="Yi, Q L" uniqKey="Yi Q" first="Q.-L." last="Yi">Q.-L. Yi</name><name sortKey="Yi, Q L" sort="Yi, Q L" uniqKey="Yi Q" first="Q.-L." last="Yi">Q.-L. Yi</name></country><country name="Australie"><noRegion><name sortKey="Mar Fan, H G" sort="Mar Fan, H G" uniqKey="Mar Fan H" first="H. G." last="Mar Fan">H. G. Mar Fan</name></noRegion></country><country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Houede Tchen, N" sort="Houede Tchen, N" uniqKey="Houede Tchen N" first="N." last="Houede-Tchen">N. Houede-Tchen</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002272 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 002272 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:10-0265852
|texte= Menopausal symptoms in women undergoing chemotherapy-induced and natural menopause: a prospective controlled study
}}
| This area was generated with Dilib version V0.6.33. |  |